Simple inputs
Bring product details, ingredients, and claims from spreadsheet or PDF intake. Validation keeps the roster explicit so mapping is repeatable—not a one-off spreadsheet crosswalk.
Portfolio mapping & regulatory signals
See concentration across products—then open the rows that matter.
Portfolio intelligence is the join between your normalized roster and RegSig’s scored signals: exposure, urgency, and ownership on every product–signal pair, with provenance for audit-ready review.
- Portfolio risk concentration
- Per-product exposure & ownership
- Scored signals with origin context
Mapping story
Upload once, map to signals, prioritize with owners
What portfolio mapping delivers
Regulatory context
Each match is grounded in signal records with origin metadata across authorities and source types, so teams see not just “a hit” but why the issue applies.
For leadership
Surface where risk and urgency concentrate across SKUs and themes—supporting portfolio prioritization without losing the underlying evidence chain.
For operators
Work the line items: exposure level, recommended action type, owner, urgency, and a concise narrative per product–signal pair for handoff and execution.
Illustrative view
Diagrams compress complexity; portfolio intelligence in product is row-level—exposure, urgency, owner, and narrative on each product–signal pair.
Signal-to-portfolio mapping (example)
One signal can touch multiple SKUs through shared ingredients or claims; this illustrative layout shows how normalized entities relate—concentration in the real product is surfaced in assessment rows, not just in diagrams.
Regulatory signal
Date marking and labeling trigger
Product
Protein Bar A
Product
Protein Bar B
Shared relationship across multiple records.
Ingredient
Ingredient: Sucralose
Shared relationship across multiple records.
Claim
Claim: Sugar-free
Shared relationship across multiple records.
Business unit
BU: North America
Who it serves
Teams that rely on portfolio intelligence
Portfolio & program leads
Compare concentration of exposure and high-urgency actions across products and signals to sequence reviews and align owners.
Regulatory affairs
Substantiate which authorities and document types drive each mapping before committing resources, using evidence-linked signal rows.
Product compliance & quality
Translate signal updates into SKU-level action lists with clear urgency and ownership for labeling, claims, and ingredient-related work.
Governance & access
Trajectory-aware signals stay tied to evidence and portfolio impact—built for operator review, not opaque alerts.
Start with individual usage-based access when you are ready. Enterprise teams use institutional onboarding with fit and governance review.
- Human-in-the-loop review stays in operator workflows.
- Recommendations remain evidence-linked and auditable.
- Portfolio mapping is role-aware with explicit ownership.